HSV-1 and HSV-2 are two closely related but distinct viruses that both cause herpes. The core difference: HSV-1 typically infects the mouth and causes cold sores, while HSV-2 almost exclusively infects the genital area. But the real distinctions go deeper than location, affecting how often outbreaks happen, how frequently the virus sheds, and what the long-term picture looks like.
Where Each Type Prefers to Live
HSV-1 mostly spreads through oral contact, passing through saliva, sores, or skin surfaces in and around the mouth. Most people pick it up during childhood from a kiss or shared utensil. It can also spread to the genitals through oral sex, which has become an increasingly common cause of genital herpes in younger adults.
HSV-2 spreads almost entirely through sexual contact with genital or anal skin, sores, or fluids. It rarely infects the mouth. When someone says “genital herpes,” they’re often thinking of HSV-2, though HSV-1 now accounts for a significant share of new genital herpes cases in many countries.
Both viruses settle permanently into nerve cells near the site of infection. HSV-1 typically takes up residence in the nerve cluster near the ear (serving the face), while HSV-2 lodges in the nerve cluster at the base of the spine (serving the genitals). This is why each type “prefers” its respective territory, though neither is strictly confined to it.
How Often Outbreaks Come Back
This is one of the most meaningful practical differences between the two types. When HSV-2 infects the genitals, it recurs frequently. When HSV-1 infects the genitals, recurrences are much less common and tend to drop off quickly after the first year.
The pattern matters for daily life. Someone with genital HSV-1 may have one initial outbreak and then rarely or never have another. Someone with genital HSV-2 is more likely to deal with multiple recurrences per year, especially in the first couple of years. Over time, outbreaks become less frequent for both types, but HSV-2 maintains a higher baseline.
For oral infections, the pattern flips in a sense: HSV-1 is well adapted to the mouth and can recur periodically as cold sores throughout life, while HSV-2 oral infections are rare and almost never recur.
Viral Shedding Between Outbreaks
Even when there are no visible sores, both viruses periodically reactivate and appear on the skin surface. This is called asymptomatic shedding, and it’s the main way herpes spreads to partners who never saw an outbreak on the infected person.
The difference in shedding rates between the two types is substantial. Research from the University of Washington tracked genital HSV-1 shedding over time and found participants shed the virus on about 12% of days at two months after infection, dropping to 7% by eleven months. Those who continued shedding were tracked further, and by two years the rate had fallen to just 1.3% of days.
HSV-2 sheds far more aggressively. In the first year of genital infection, shedding occurs on roughly 34% of days. Even at ten years, the rate remains around 17% of days. In most cases, participants had no symptoms during shedding episodes, which is why HSV-2 spreads so efficiently between sexual partners who aren’t aware of the infection.
How Prevalent Each Type Is
HSV-1 is extraordinarily common. The WHO estimates that roughly 3.7 billion people under age 50 carry HSV-1 globally. In many regions, the majority of adults are infected, often without knowing it because their infections are mild or completely silent.
HSV-2 is less widespread but still affects hundreds of millions of people. Because it spreads primarily through sex, infection rates rise after adolescence and vary more by region and population. Many people with HSV-2 have never had a recognized outbreak and don’t know they carry the virus.
Genetic Differences Under the Surface
Despite causing similar-looking sores, these two viruses are more different genetically than you might expect. HSV-2 is actually more closely related to chimpanzee herpes virus than it is to HSV-1, suggesting the two types diverged a very long time ago in primate evolutionary history.
Both have genomes about 152 to 155 kilobases long (medium-sized for a virus), but they differ in how quickly they mutate. HSV-2 generates new genetic variants at a much higher rate than HSV-1 under comparable conditions. Most of these mutations change the structure of viral proteins rather than being silent, which may help explain some of the behavioral differences between the types, like HSV-2’s more aggressive shedding and recurrence patterns. The mutation rate difference doesn’t appear to come from the virus’s copying machinery alone; other viral proteins and structural features of the genome likely play a role.
Testing and Telling Them Apart
If you have an active sore, a swab test using PCR can identify whether HSV-1 or HSV-2 is responsible. This is the most reliable way to type the infection.
Blood tests can also distinguish between the two types by detecting antibodies to a protein called glycoprotein G, which differs enough between the viruses (sharing only about 40% of its structure) to serve as a reliable marker. These type-specific blood tests generally perform well, though accuracy varies by manufacturer. For HSV-2 detection, sensitivity ranges from about 85% to 97% depending on the test platform, with specificity consistently above 94%. HSV-1 blood tests tend to be slightly less sensitive, ranging from about 80% to 95%.
One practical note: blood tests detect antibodies, which take time to develop. Testing too soon after exposure can produce a false negative. Antibodies to HSV-2 typically appear within a few weeks, but some people take up to 12 weeks to develop detectable levels.
Risks During Pregnancy
Both types carry a risk of transmission to a newborn during delivery, but the timing of the mother’s infection matters more than the virus type. A first-time infection acquired during the second half of pregnancy poses the highest danger, with a 30 to 50% chance of passing the virus to the baby without intervention. This risk applies equally to HSV-1 and HSV-2.
For women with a long-standing infection, the risk is much lower because the body has had time to build antibodies that partially protect the baby. Antiviral medication in the final weeks of pregnancy and, when necessary, cesarean delivery further reduce transmission risk.
Treatment Is the Same for Both
The same antiviral medications work against both HSV-1 and HSV-2. These drugs shorten outbreaks, reduce their severity, and lower the frequency of recurrences when taken daily as suppressive therapy. They also reduce (but don’t eliminate) asymptomatic shedding.
Because HSV-2 recurs more often and sheds more frequently, people with genital HSV-2 are more likely to benefit from daily suppressive therapy. Those with genital HSV-1 often find that outbreaks are infrequent enough that they only need medication during an active episode, if at all. Oral HSV-1 (cold sores) can be treated the same way, with episodic or suppressive antiviral use depending on how often outbreaks occur.
Neither virus can be cured. Both establish lifelong infections in nerve cells, where they remain dormant between reactivations. The practical difference comes down to how much the virus disrupts daily life: for most people with HSV-1, the answer is very little, while HSV-2 tends to be more persistent and requires more active management.